| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/24/1996 | EP0722463A1 Methods and composition for the modulation of host immune response to allergens |
| 07/24/1996 | EP0722462A1 Dna encoding prostaglandin receptor ip |
| 07/24/1996 | EP0722460A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 07/24/1996 | EP0722459A1 Hemoregulatory penta- or hexapeptides |
| 07/24/1996 | EP0722457A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 07/24/1996 | EP0722456A1 Antifungal compositions |
| 07/24/1996 | EP0722452A1 Nf-at polypeptides and polynucleotides |
| 07/24/1996 | EP0722449A1 Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring |
| 07/24/1996 | EP0722438A1 Hydroxamic acid derivatives as inhibitors of cytokine production |
| 07/24/1996 | EP0722344A1 Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained |
| 07/24/1996 | EP0722343A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 07/24/1996 | EP0722342A1 REGULATION OF bcl-2 GENE EXPRESSION |
| 07/24/1996 | EP0722338A1 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 07/24/1996 | EP0722337A1 Cd8?+ cell antiviral factor |
| 07/24/1996 | EP0722335A1 Method of treating septic shock by preventing actin polymerization |
| 07/24/1996 | EP0722334A1 Therapeutic treatment for inhibiting blood vessel blockage using a polypeptide |
| 07/24/1996 | EP0722333A1 Method of treating depressed reticuloendothelial system function |
| 07/24/1996 | EP0722332A1 Compounds for medicinal use |
| 07/24/1996 | EP0722331A1 Method for producing a highly enriched population of hematopoietic stem cells |
| 07/24/1996 | EP0722328A1 Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta |
| 07/24/1996 | EP0722327A1 Improvements relating to antibacterial compositions |
| 07/24/1996 | EP0722324A1 Pharmaceutical composition for immunoenhancement therapy |
| 07/24/1996 | EP0722321A1 Sulfoximine and sulfodiimine matrix metalloproteinase inhibitors |
| 07/24/1996 | EP0722320A1 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
| 07/24/1996 | EP0722318A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 07/24/1996 | EP0722275A1 Cell death regulator |
| 07/24/1996 | EP0665850A4 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions. |
| 07/24/1996 | EP0626858A4 Antiviral agent. |
| 07/24/1996 | EP0612250B1 Methods and compositions relating to useful antigens of moraxella catarrhalis |
| 07/24/1996 | EP0560968B1 Vaccine for neisseria meningitidis infections |
| 07/24/1996 | EP0396612B1 Novel plasmid vector with pectate lyase signal sequence |
| 07/24/1996 | CN1127532A Method for diagnosing a disorder by determining expression of GAGE tumor rejection antigen precursors |
| 07/24/1996 | CN1127529A Agonists and antagonists of human interleukin-10 |
| 07/24/1996 | CN1127528A Modified alpha-lactalbumin |
| 07/24/1996 | CN1127527A Ribozyme gene therapy for HIV infection and Aids |
| 07/24/1996 | CN1127509A New peptide derivatives |
| 07/24/1996 | CN1127471A Compositions for inhalation |
| 07/24/1996 | CN1127259A Peptides |
| 07/24/1996 | CA2167763A1 Mercaptoalkyldipeptide derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 07/24/1996 | CA2140814A1 Use of calreticulin in modulating hormone responsiveness and new pharmaceuticals for treating cancer, osteoporosis and chronic inflammatory disease |
| 07/23/1996 | US5539122 Retroviral protease inhibiting compounds |
| 07/23/1996 | US5539096 Genes differentially expressed in metastatic and non-metastatic rat rhabdomyosarcoma cell lines |
| 07/23/1996 | US5539094 DNA encoding Bcl-2-associated proteins |
| 07/23/1996 | US5539086 Therapeutic fragments of von Willebrand factor |
| 07/23/1996 | US5539085 Polypeptide complex, screening for agents which inhibit certain cancers, agents which modulate cell growth |
| 07/23/1996 | US5539082 Peptide nucleic acids |
| 07/23/1996 | US5539063 Polymer for making poly(ethylene glycol)-protein conjugates |
| 07/23/1996 | US5538982 Medical use for tachykinin antagonists |
| 07/23/1996 | US5538954 Sucrose octa-o-sulfonic acid salts of tetracyclines for inhibiting protein synthesis |
| 07/23/1996 | US5538952 Using human casein |
| 07/23/1996 | US5538951 Dipeptides of glutamic acid and tryptophan for immunology |
| 07/23/1996 | US5538950 Endothelin antagonists and their preparation |
| 07/23/1996 | US5538949 Angiogenesis inhibitors |
| 07/23/1996 | US5538948 Method for treating infertility comprising administering GnRH analog, gonadotrophins, and growth hormone |
| 07/23/1996 | US5538947 Growth inhibitory factor |
| 07/23/1996 | US5538946 Hirudin derivatives with delayed action |
| 07/23/1996 | US5538945 Stimulation of hair growth by peptide copper complexes |
| 07/23/1996 | US5538866 Immunoassay; medical diagnosis |
| 07/23/1996 | US5538865 Antigens for viral hepatitis |
| 07/23/1996 | US5538861 DNA encoding a stimulating factor for the axl receptor |
| 07/23/1996 | US5538854 Method for the determination of predisposition to autoimmune disease |
| 07/23/1996 | US5538845 Beta-amyloid peptide production inhibitors and methods for their identification |
| 07/23/1996 | US5538844 Transport protein gene from the Huntington's disease region |
| 07/23/1996 | US5538739 Sustained release formulations of water soluble peptides |
| 07/23/1996 | US5538729 Oral treatment of helicobacter infection |
| 07/23/1996 | US5538727 Hyperimmunizing qvians eggs |
| 07/23/1996 | US5538725 Method of inhibiting metastasis by anti-α6-integrin-antibodies |
| 07/23/1996 | US5538724 Method of control leukocyte extravasation |
| 07/23/1996 | US5538721 Stabilization of aminosteroids for topical ophthalmic and other applications |
| 07/23/1996 | CA2060509C Human monoclonal antibody to glycoprotein gpiii of varicella zoster virus |
| 07/23/1996 | CA1338484C 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use |
| 07/23/1996 | CA1338466C Manipulation of ovulation and spawning in fish |
| 07/21/1996 | CA2167456A1 Use of l-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-a and other immunodeppresant drugs |
| 07/18/1996 | WO1996021740A1 Methods of determining endogenous thrombin potential (etp) and thrombin substrates for use in said methods |
| 07/18/1996 | WO1996021736A1 Human geranylgeranyl pyrophosphate synthetase |
| 07/18/1996 | WO1996021734A2 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/18/1996 | WO1996021733A2 Transfert of dna in cells with the view to correcting the adrenoleucodystrophy |
| 07/18/1996 | WO1996021732A1 Il-2r-associated polypeptide and dna molecules coding therefor |
| 07/18/1996 | WO1996021731A2 Stabilized external guide sequences |
| 07/18/1996 | WO1996021730A2 Ribozymes with rna protein binding site |
| 07/18/1996 | WO1996021726A1 Identification of a distinct retinoid-responsive pathway and uses therefor |
| 07/18/1996 | WO1996021724A1 Human deoxycytidine kinase 2 |
| 07/18/1996 | WO1996021676A1 Growth factor analogs |
| 07/18/1996 | WO1996021674A1 Novel peptides, their production and use |
| 07/18/1996 | WO1996021673A1 Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen |
| 07/18/1996 | WO1996021672A1 Immunotherapeutic agent derived from bacteria |
| 07/18/1996 | WO1996021671A1 Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
| 07/18/1996 | WO1996021655A2 Substituted oxazolidine calpain and/or cathepsin b inhibitors |
| 07/18/1996 | WO1996021471A1 Compositions and methods for treating tumor cells |
| 07/18/1996 | WO1996021468A2 Chemically modified interferon |
| 07/18/1996 | WO1996021464A1 Compositions for the delivery of antigens |
| 07/18/1996 | WO1996021463A2 New applications of lysozyme dimer |
| 07/18/1996 | WO1996021462A1 Pharmaceutical compositions comprising a superoxide dismutase |
| 07/18/1996 | WO1996021461A1 A stabilized pharmaceutical formulation comprising a growth hormone and leu-his-leu |
| 07/18/1996 | WO1996021460A1 A stabilized pharmaceutical formulation comprising a growth hormone and x-lys |
| 07/18/1996 | WO1996021459A1 A stabilized pharmaceutical formulation comprising a growth hormone and lys-x |
| 07/18/1996 | WO1996021458A1 Collagen-based methods and formulations for the treatment of immune system-mediated diseases |
| 07/18/1996 | WO1996021456A1 Inhibitors of prenyl transferases |
| 07/18/1996 | WO1996021436A1 Improved therapeutic compositions comprising bactericidal/permeability-increasing (bpi) protein products |
| 07/18/1996 | WO1996021421A1 Nutrient medium for use as a culture medium for epidermal cells, and uses thereof |